IPCA Laboratories Share price target & analyst calls
₹1,903.5-15.40 (-0.80%)
Only one active 1-year target
The long-term call is BUY₹2,0608.2% above today's price
IPCA Laboratories has one active 1-year share price target: ₹2,060 from Motilal Oswal (14 Aug 2026). One target is a single view, not a consensus.
4
4 BUY · 0 SELL, all horizons
1
with an active 1Y target
46%
17 of 37 closed calls hit
41
all horizons, open and closed
Watch IPCALAB for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (41)
MObyMotilal Oswal+8.2% to target
1 Year* · 10 mo left · 14 Aug 2026 · entry ₹1,734.2 · via Institutional / Brokerage ResearchP&L +9.8%
EGbyEmkay GlobalTarget hit
1 Year* · 17 Aug 2026 · entry ₹1,884.6 · via Institutional / Brokerage Researchexit ₹1,950
EGbyEmkay GlobalTarget hit
1 Year* · 2 Jun 2026 · entry ₹1,507.7 · via Institutional / Brokerage Researchexit ₹1,800
ISbyICICI SecuritiesTarget hit
1 Year* · 2 Jun 2026 · entry ₹1,507.7 · via Institutional / Brokerage Researchexit ₹1,845
MObyMotilal OswalTarget hit
1 Year* · 1 Jun 2026 · entry ₹1,490.4 · via Institutional / Brokerage Researchexit ₹1,730
MObyMotilal OswalTarget hit
1 Year* · 17 Mar 2026 · entry ₹1,565.3 · via Institutional / Brokerage Researchexit ₹1,820
PLbyPrabhudas LilladherTarget hit
1 Year* · 6 Mar 2026 · entry ₹1,494.2 · via Institutional / Brokerage Researchexit ₹1,800
PLbyPrabhudas LilladherTarget hit
1 Year* · 17 Feb 2026 · entry ₹1,491.6 · via Institutional / Brokerage Researchexit ₹1,710
ISbyICICI SecuritiesTarget hit
1 Year* · 17 Feb 2026 · entry ₹1,491.6 · via Institutional / Brokerage Researchexit ₹1,800
MObyMotilal OswalTarget hit
1 Year* · 16 Feb 2026 · entry ₹1,495.1 · via Institutional / Brokerage Researchexit ₹1,720
ISbyICICI SecuritiesTarget hit
1 Year* · 17 Nov 2025 · entry ₹1,464.8 · via Institutional / Brokerage Researchexit ₹1,660
MObyMotilal OswalTarget hit
1 Year* · 13 Nov 2025 · entry ₹1,302 · via Institutional / Brokerage Researchexit ₹1,600
SRbySharekhan ResearchTarget hit
1 Year* · 30 Sept 2024 · entry ₹1,498.1 · via Institutional / Brokerage Researchexit ₹1,734
SRbySharekhan ResearchTarget hit
1 Year* · 14 Aug 2024 · entry ₹1,349.05 · via Institutional / Brokerage Researchexit ₹1,600
VSbyVikas Sethi, Sethi FinmartStop-loss hit
1 Year · 8 Oct 2026 · entry ₹1,960 · via Zee Business (Live)exit ₹1,800
VSbyVikas Sethi, Sethi FinmartStop-loss hit
1 Year · 24 Sept 2026 · entry ₹1,990 · via Zee Business (Live)exit ₹1,825
MObyMotilal OswalExpired
1 Year* · 27 Dec 2024 · entry ₹1,632.65 · via Institutional / Brokerage Researchexit ₹1,439.8
SRbySharekhan ResearchExpired
1 Year* · 14 Nov 2024 · entry ₹1,536.55 · via Institutional / Brokerage Researchexit ₹1,479.6
MObyMotilal OswalExpired
1 Year* · 14 Oct 2024 · entry ₹1,682.2 · via Institutional / Brokerage Researchexit ₹1,306.1
VSbyVikas Sethi, Sethi Finmart+12.9% to target
1–3 Months · 4 wk left · 18 Aug 2026 · entry ₹1,882.9 · via Zee Business (Live)P&L +1.1%
RVbyRaja Venkatraman+12.9% to target
1–3 Months · 4 wk left · 18 Aug 2026 · entry ₹1,890 · via LiveMint MarketsP&L +0.7%
VSbyVikas Sethi, Sethi FinmartTarget hit
1–3 Months · 16 Sept 2026 · entry ₹1,927 · via Zee Business (Live)exit ₹2,010
SSbySudeep Shah, SBICAP SecuritiesStop-loss hit
1–3 Months* · 5 Oct 2026 · entry ₹1,960 · via Zee Business (Live)exit ₹1,900
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 10 Jul 2026 · entry ₹1,792 · via IDBI Capital Research Calls Telegramexit ₹1,720
MJbyManas Jaiswal+5.1% to target
1–2 Weeks* · 13d left · 22 Oct 2026 · entry ₹1,905.4 · via CNBC Awaaz.P&L -0.1%
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 13 Aug 2026 · entry ₹1,790 · via IDBI Capital Research Calls Telegramexit ₹1,868
AAbyAditya Agarwal, Coheron BrokersTarget hit
1–2 Weeks* · 23 Jun 2026 · entry ₹1,626 · via Business Todayexit ₹1,700
VSbyVikas Sethi, Sethi FinmartStop-loss hit
1–2 Weeks* · 1 Oct 2026 · entry ₹1,940 · via Zee Business (Live)exit ₹1,905
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 25 Sept 2026 · entry ₹2,020 · via Zee Business (Live)exit ₹1,970
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 17 Sept 2026 · entry ₹1,995 · via IDBI Capital Research Calls Telegramexit ₹1,937
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 7 Sept 2026 · entry ₹1,975 · via IDBI Capital Research Calls Telegramexit ₹1,945
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 17 Aug 2026 · entry ₹1,908.1 · via CNBC Awaaz.exit ₹1,850
SBbySumeet Bagadia, Choice BrokingStop-loss hit
1–2 Weeks* · 6 Aug 2026 · entry ₹1,765 · via LiveMint Buy-or-Sell (topic)exit ₹1,700
KBbyKush BohraExpired
1–2 Weeks* · 21 Aug 2026 · entry ₹1,900.1 · via NDTV Profit (Live)exit ₹1,957.3
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.6% · 19 calls
- CIPLACipla Ltd.₹1,524+14.5% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+26.6% · 15 calls
- BIOCONBiocon Ltd₹485+46.9% · 12 calls
- LUPINLupin Limited₹2,576+34.1% · 12 calls
- IPCALAB· this stockIPCA Laboratories Limited₹2,060+8.2% · 1 call